ICL (ICL) SVP Meshulam Amir reports sizable stock option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ICL Group Ltd. executive Meshulam Amir, SVP Global Internal Audit, reported his initial ownership of stock options in a Form 3 filing. He holds fully vested options over 206,557 Ordinary Shares with a $9.39 exercise price, expiring on February 8, 2027. He also holds options over 275,547 Ordinary Shares at a $5.87 exercise price, expiring on April 4, 2029, which vest in three equal annual installments starting from April 4, 2025. The options are held by a trustee in his name, and this filing reflects holdings rather than new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Meshulam Amir
Role
SVP, Global Internal Audit
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 206,557 shares (Direct)
Footnotes (1)
- The stock options are fully vested and exercisable. The stock options vest in three equal annual installments from the April 4, 2025, grant date. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
Key Figures
Option grant 1 underlying shares: 206,557 shares
Option grant 1 exercise price: $9.39 per share
Option grant 2 underlying shares: 275,547 shares
+5 more
8 metrics
Option grant 1 underlying shares
206,557 shares
Ordinary Shares underlying fully vested options at $9.39 exercise price
Option grant 1 exercise price
$9.39 per share
Exercise price for options expiring February 8, 2027
Option grant 2 underlying shares
275,547 shares
Ordinary Shares underlying options at $5.87 exercise price
Option grant 2 exercise price
$5.87 per share
Exercise price for options expiring April 4, 2029
Vesting schedule
3 equal annual installments
Vesting pattern from April 4, 2025 grant date
NIS exercise price 1
NIS 29.57
Local-currency exercise price converted using $1.00 = NIS 3.149
NIS exercise price 2
NIS 18.47
Second local-currency exercise price using same $1.00 = NIS 3.149 rate
Exchange rate used
$1.00 = NIS 3.149
Bank of Israel representative exchange rate as of March 27, 2026
Key Terms
Stock Options (Right to Buy), Ordinary Shares, fully vested and exercisable, three equal annual installments, +2 more
6 terms
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
fully vested and exercisable financial
"The stock options are fully vested and exercisable."
three equal annual installments financial
"The stock options vest in three equal annual installments from the April 4, 2025, grant date."
Bank of Israel representative exchange rate financial
"converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149"
Trustee financial
"The options are held by a Trustee in the name of the Reporting Person."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
FAQ
What does the ICL Form 3 filed by Meshulam Amir report?
The Form 3 reports SVP Global Internal Audit Meshulam Amir’s initial ownership of stock options in ICL Group Ltd.. It lists two option grants over ordinary shares, including exercise prices, expiration dates, and vesting terms, without showing any recent option exercises or share sales.
How many ICL stock options does Meshulam Amir hold according to the Form 3?
According to the filing, Meshulam Amir holds options over 206,557 Ordinary Shares at $9.39 per share and options over 275,547 Ordinary Shares at $5.87 per share. These totals represent his reported derivative positions, not currently exercised shares of ICL common stock.
What are the exercise prices and expirations of Amir’s ICL stock options?
One ICL option grant has a $9.39 exercise price and expires on February 8, 2027. The other grant has a $5.87 exercise price and expires on April 4, 2029. These figures indicate the prices and timeframes for potentially converting options into ordinary shares.
How do the vesting terms work for Amir’s ICL stock options?
The filing notes one set of options is fully vested and exercisable. The other set vests in three equal annual installments beginning on April 4, 2025. This means those options become exercisable gradually over three years from the stated grant date.
Are Meshulam Amir’s ICL options held directly or through a trustee?
The Form 3 states the options are held by a Trustee in the name of the Reporting Person. Economically they are attributed to Amir, but the trustee is the formal holder. This structure is common in employee equity plans, especially where local regulations encourage trustee arrangements.
Does the ICL Form 3 show any recent buying or selling by Meshulam Amir?
No, the Form 3 functions as an initial ownership report and lists existing stock option holdings. The transaction summary shows no buys or sells and classifies entries as holdings, indicating there were no new market purchases, sales, or option exercises reported in this filing.